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ABSTRACT
Eukaryotic genes architecture is characterized by incorporation of non-coding
sequences interrupting the coding sequences. Through splicing, excision of those noncoding sequences, known as introns, is taking place co-transcriptionally, i.e.
synchronically with the synthesis of precursor messenger m-RNA from the template
DNA, in a precisely-regulated manner. Alternative splicing is a phenomena where not all
splice sets are used in each transcript processed. Thus, this process enhances the proteome
and transcriptome complexity through generating different transcripts, with different
functionality or stability, from a single gene. Aberrant splicing have been associated with
a lot of disease including cancer as well as Parkinsonism. Chemical compounds or drugs
that target splicing regulation have also been developed and characterized.
Indole derivatives have proven before their potency in targeting serine-arginine rich
splicing regulators of alternative splicing. In this study, alternative splicing in Arabidopsis
have been targeted through three different Indole derivatives, 6-Methylindole, 2, 5Dimethylindole and 5-Bromoindole-2-Carboxylic Acid. Full transcriptomic analysis of the
RNA-seq data generated from treated samples, at both 24 and 72 hrs time points, was
conducted to reveal the alternative splicing modulation and gene expression patterns
changes under those splicing modulators treatment. Interestingly, observation of splicing
pattern alteration under the influence of Indole derivatives used in this study indicate that
most treatments, 4 out of 6, and specifically after certain onset of time 72 hrs, showed
significant enhancement of AS, mostly through intron retention splicing events.
Photorespiration related genes were altered frequently, on AS and/or expression level,
under different Indole derivatives treatments and time points. More interestingly, RNA
binding proteins and splicing factors were differentially spliced, a finding that is consistent
with the prevalence of auto-regulatory nature of those genes.Furthermore, various
potential functional outcomes may originate from differential splicing exhibited under
Indole treatments. In hydrolase-like protein (AT5G17670), an alternative 5’ splice site
skipped a pre-mature termination codon. In SR34a SR splicing factor, exon skipping event
at the 5’ untranslated region might help the transcript escape regulatory miRNAs. Overall,
this study shall introduce a transcriptomic snapshot of Genome-wide gene expression and
alternative splicing after targeting serine-arginine splicing factors by Indole derivatives.
II
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Chapter One: Introduction and study objectives
1.1. Precursor m-RNA splicing in eukaryotes:
Once transcription starts inside the nucleus, multiple processes will cooperate to
harmonize the flow of expressed information encoded in the genome to guarantee its
accordance with the desired cellular functions. Major processes include messenger RNA
(m-RNA) 5’ end capping, splicing and 3’ end polyadenlyation (addition of poly (A) tail at
the 3’ end of the m-RNA. Further, m-RNA bases covalent modification, editing,
degradation, localization, export to translation site in cytoplasm and translation initiation
control are contributing to the processes of m-RNA expression tuning. [1] Together, those
processes are known as post-transcriptional modifications. The recognition of the posttranscriptional modifications as critical key players in regulation almost all physiological
process in plants is remarkably increased. [2-8]
The incorporation of non-coding sequences interrupting the coding sequences is a
unique characteristic of eukaryotic genes architecture and a fundamental difference from
prokaryotic genes.[9-11] In splicing, excision of those non-coding sequences, known as
introns, is taking place co-transcriptionally, i.e. synchronically with the synthesis of
precursor messenger m-RNA (pre m-RNA) from the template DNA, in a preciselyregulated manner.[11] A precursor m-RNA is processed into mature m-RNA by removal
of introns and ligation of the remaining flanking coding sequences, known as exons,
through two trans-esterification reactions into mature m-RNA molecule. This molecule
then becomes ready to be transported from the transcription and processing site, nucleus,
to the translation site, the cytoplasm, where ribosomes will translate it into a functional
entity, a protein.
Precursor m-RNA splicing is performed by one of the largest complexes of the
eukaryotic cell, the splicesome. Splicing machinery of the splicesome is a multifunctional
tool that is responsible and capable of selection of splice sites (i.e. introns and exons
sequences and junction’s definition) as well as exon-exon ligation and introns removal.
Based on whether a single set or multiple sets of splice sites can be identified for a certain
gene, any gene can undergo either a constitutive splicing (CS) or an alternative splicing
(AS). In constitutive splicing, a single set of splice sites is utilized by the splicing
machinery to produce a single mature m-RNA and a single protein from a single gene.[12,
1

13] On the other hand, in alternative splicing, splicing machinery has the potential to
process the pre m-RNA in different ways by utilizing different combinations of splice
sites, and as a result, generate different sets of mature m-RNAs, called splice variants or
transcripts. Those different transcripts, consequently, are then translated and utilized to
generate different proteins, which originated basically from the same single gene.[13, 14]
Those different proteins generated from the same gene through AS can exhibit altered or
modified function(s) (activity/interaction/binding properties), subcellular localization and
stability.[15] Accordingly, alternative splicing is considered a major mechanism through
which eukaryotes can enhance the coding potential of their genomes, increase
transcriptome plasticity and proteome diversity. More interestingly, AS is believed to play
a role in modulation of genes expression through modifying the relative abundances of
functional and non-functional splice variants by non-sense mediated decay (NMD) along
with controlling their recruitment to ribosomes and translation efficiency.[16-18] Thus,
AS shall be regarded as a critical mechanism of post-transcriptional regulation of m-RNA.
Interestingly, AS was found to be extensively prevalent in intron-containing genes
in human, as up to 95% of those genes shows an alternative splicing pattern of their pre mRNA.[19, 20] In plants, almost over 40% of intron-containing genes undergo alternative
splicing.[21, 22] Recently, full transcriptome coverage techniques and de novo
transcriptome assembly software have estimated the percentage of alternatively spliced
genes to be 61% of intro-containing genes in Arabidopsis Thaliana.[23, 24] However, this
prevalence of alternative splicing may increase through the continuous discovery of novel
splice variants recruited in different developmental stages, organs, cell types or states of
response to abiotic and biotic stress. [24-30]

1.2. Mechanism of splicing
In eukaryotes, short consensus sequences lie within the introns (mostly at the
exon/intron borders) are responsible for guiding the recruitment of different components
of splicing machinery to the splice site. (See Fig 1.1) At the beginning of an intron,
5’splice site is almost 9 nucleotide long with a consensus start GU dinucleotide. On the
other end, 3’ splice site of an intron has a consensus AG dinucleotide. Further, a
pyrimidine rich region, called the polypyrimidine tract, is located upstream of the 3’splice
site. Upstream from the polypyrimidine tract, an A sequence, called a branch point, is
2

recognized by spliceosome during the first step of splicing. Collectively, those sequences,
known as splicing signals or splicing sites, are essential components of pre-mRNA for
substrate recognition and catalysis by the core splicing machinery.[12] Other group of
RNA motifs, known as splicing regulatory elements (SRE), are divided into two main
types; splicing enhancers and silencers. Interestingly, they can lie within both introns and
exons, thus result in complex context-dependent splicing regulation. (reviewed in [31]).
Structurally, the spliceosome, one of the largest macromolecular complexes of a
eukaryotic cell, is composed of both non coding RNAs as well as a plethora of protein
splicing factors. The assembly of different splicesomal components at splicing sites is
precisely ordered to functionally regulate and accomplish splicing of the substrate pre mRNA.[32-35]
The key structure of a splicesome contains five small nuclear ribonucleoprotein complexes
(snRNPs), designated U1,U2,U4,U5,U6. Each complex consists of a small nuclear RNA
as well as definite set of protein factors. Those small nuclear RNAs are basically short,
Uridine rich, non-coding, non-polyadenylated transcripts which also referred to as U1, U2,
U4, U5, U6 snRNAs based on the Ribonucleoprotein complex they contribute to. The core
proteins utilized in the structure of U1, U2, U4, U5 snRNPs belong mainly to the Sm
protein family, for Smith, an autoimmune disease where patient develop antibodies against
those proteins. However, the snRNP U6 is utilizing the related Sm-Like proteins (Lsm2 to
Lsm8) in association with snRNAs in its core structure. [36]
The splicing process starts as UI snRNP interacts with the 5’ splice site of an intron.
This interaction is mediated by base-pairing of the U1 snRNA to its complementary
sequences within the pre-mRNA. The U2 two auxiliary factors subunits binds to the 3’
splice site. While the U2AF 35 kDa bind to the intron-exon border, the U2AF 65 kD bind
to the polyprimidine tract upstream of the 3’ splice site. All the previous events lead to
formation what’s called complex E. Afterwards, U2 snRNP is interacting with the branch
point via base-pairing of U2 snRNA to form complex A. Later, an assembly of the three
complexes U4, U5, U6, is docking to the snRNP in order to form the pre-catalytic
complex B that is made up of the whole five snRNPs. Subsequently, major rearrangements
happen, leading to release of both U1 and U4 snRNPs as well as the formation of an
activated complex B.
3

Once an activated complex B is formed, the splicing reaction is initiated through
the first trans-esterification reaction that includes cleavage of the pre-m-RNA 5’s splice
site and ligate it to the branch point to form a lariat of the intron sequences. The second
trans-esterification reaction takes place through cleavage of the 3’ splice site, ligating the
two exons and release the mature spliced mRNA. The lariat released is then degraded and
all snRNPs are recycled and recruited to other splicing process.[32] Within the catalytic
cycle, other enzymes may contribute to the process. For example, ATP-dependent RNA
helicases can help reconfiguring RNA-RNA interactions between snRNPs RNA and premRNA. [37]
This process of pre- m RNA splicing was mainly described and characterized in
both mammalian and yeast through biochemical purification of different components of
the spliceosome as well as in vitro splicing functional assays. However, the splicing
process hasn’t been studied extensively in plants, in apart because the lack of an in vitro
splicing assay that recapitulates the splicing reaction in plant systems. Although plant
introns have been shown to be precisely spliced in HeLa nuclear extract, mammalian
introns weren’t efficiently spliced in plants, referring to a possible differences in the intron
recognition mechanisms. [38-40]This may be, in part, due to the huge difference between
the length of introns between animal, with intron length average 5 kb, and plants, where
intron length average is only 160 bp.[41] Moreover, intron sequence composition is
considered to be important, with high UA content of plant introns permits efficient
splicing. [40-42]
In Arabidopsis Thaliana’s genome, most of the mammalian and yeast splicing
factors and U snRNA counterparts have been identified. That suggests that the main
central mechanism and process of splicing reaction are conserved.[43, 44] Furthermore,
the frequent presences of some paralogs is referring to a probable level of redundancy in
function among splicing factors families.

1.3. Mechanism of Alternative Splicing
The molecular mechanism of alternative splicing is mediated by differential use of
some splice sites, so that not all splice sites are used to generate the mature mRNA. As a
result, some exons can be skipped and removed with the flanking intron, a splicing event
called exon skipping. In other events, whole introns can be retained, designated as intron
4

retention. (See Fig 1.2). More interestingly, in some events, different 5’ or 3’ splice sites
can be utilized to incorporate variable parts of the exon or to remove variable parts of the
intron. Those processes are known as alternative donor and alternative acceptor splicing
events. Those splicing events contribute to the major differences between mRNA isoforms
generated from the same gene. Encoded proteins from those different isoforms can entail
different domain, as a sequence different biological functions. [45] Further, variations of
the sequences of those alternative spliced isoforms can promote differential stability,
translatability, regulation by microRNAs or subcellular localization. Some isoforms may
be directed to RNA decay pathways as a results of alternative splicing. For example, one
isoform that contain a retained intron can exhibit open reading frame pre-mature
termination due to stop codon in this intron. Also, if alternative splicing add or remove a
sequence not divided by three, that may lead to shift of the open reading frame and
inclusion of a pre-mature termination codon (PTC). Those PTCs can be recognized
through NMD that rapidly and efficiently filter the cell’s transcriptome from PTC
containing isoforms, thus saving the cell resources and energy waste on producing
aberrant nonfunctional proteins [46-50]. Consequently, alternative splicing coupling to
NMD may cause quantitative changes of overall and functional transcripts expression
levels. [46, 51]

1.4 Regulation of Alternative splicing
However conserved splice sites are the signals that guide the spliceosome where to
splice, pre m-RNA contain other sequence motifs that interact with the RNA-binding
proteins to regulate the usage of splice sites. Motifs are divided according to the
consequence of binding to them into splicing enhancers and silencers, which can be
located within both exons and introns.[52] This interaction between those cis-acting
motifs in the pre m-RNA and RNA binding proteins trans-acting splicing factors to
determine the splicing reactions outcomes is designated as the splicing code.(see Fig 1.3)
[53, 54]In metazoans as well as plants, there are two main classes of splicing factors;
serine-arginine rich proteins and heterogeneous nuclear Ribonucleoproteins.[31] In
Arabidopsis Thaliana, a lot of trans-splicing factors have been identified in the genome.
Their role in regulating alternative splicing in the context of growth, development and
response to biotic or abiotic stress is undoubtedly of huge importance to understand a lot
5

of the plant’s physiological and pathological processes.

1.4.1 Serine-arginine rich proteins
Serine-arginine rich proteins are group of proteins that entails mainly two types of
domain; (1) one or two RNA- recognition motifs (RRMs) that binds to cis-acting motifs
on mRNA and (2) serine-arginine rich (RS) domain that mediates protein-protein
interactions.[55, 56] Eighteen SR proteins have been identified in Arabidopsis Thaliana
genome. However eight of them have counterparts in metazoans, the rest ten proteins are
plant specific. [55, 57, 58] Moreover, plant genomes show expansion of SR proteins.
While 18 SR genes have been found in Arabidopsis, only 12 have been found in humans.
Ectopic expression of different SR proteins have led to various physiological and
morphological phenotypes and affected alternative splicing of a set of genes.[59, 60]
Alternative splicing of SR proteins has been extensively studied. Interestingly, a lot
of SR proteins were found to auto-regulate their own expression through alternative
splicing to produce PTC containing transcripts. Those transcripts either got translated into
aberrant proteins that lack one or more functional domains or got degraded through NMD
pathway. As a consequence, those events lead to alterations in transcripts abundance and
functionality. [60-64]Conservation of alternative splicing of SR proteins evolutionarily
suggests a physiological relevance of splicing pattern.[65]
It has been found that alternative splicing of SR protein RS31 across different light
regimes to be regulated through reduced pool of plastquine in chloroplasts, suggesting that
the retrograde signaling may use alternative splicing to orchestrate nuclear gene
expression. [66]

1.4.2 Heterogeneous Nuclear Ribonucleoproteins
Second class of splicing regulators are called heterogeneous Nuclear
Ribonucleoproteins (hnRNPs).[67] They entails two main group of splicing factors; polypyrimidine tract binding proteins and glycine rich proteins.
Poly-pyrimidine binding proteins are collection of factors that bind to
polyprimidine rich motifs on introns. Extensively studies about those factors in mammals
have revealed that they can repress or activate recognition of splice sites close to their
binding sites. Further, it was found that the action of those factors can be mediated
through combinatorial manner with other hnRNPs as well as other SR proteins. [68, 69]
6

More importantly, both poly-pyrimidine tract binding PTB1 and PTB2 shows
negative auto-regulation through inclusion of PTC by a cassette exon splicing event.[70]
RNA-seq analysis of the transcriptome of Arabidopsis Thaliana after over-expression or
knock-down of PTB1 and PTB2 showed an altered splicing pattern of a plethora of
transcripts.[24, 71]
Glycine rich proteins is a group of small RNA binding proteins found in higher
plants and represents a simplified version of mammalian hnRNPs. Those proteins harbor
RRM domain at N-terminal and a glycine stretch at the C-terminal. They have been found
to be involved in plant responses to environmental stresses. Two family members AtGRP7
and AtGRP8 have a prevalent role in alternative splicing. Both proteins were found to play
a regulatory rule in circadian timing system. AtGRP7 undergoes negative auto-regulation
through binding to its own m-RNA. This binding lead to usage of a cryptic splice site that
generates a transcript subject to NMD. AtGRP8 uses the same negative feedback loop to
control its own expression. Even more interestingly, they reciprocally cross regulate each
other‘s expression. They exhibit the first posttranscriptional feedback loop in the circadian
system of any organism. [72-76]

1.5 Alternative splicing role in plant adaptation to environmental stresses
1.5.1 Splicing regulation in stress response
Due to the sessile nature of plants, they can be easily affected by change in
environmental conditions. Significant changes in ambient light, temperature, or soil’s salt
and water content, together referred to as abiotic stress, can greatly influence plant
performance. In order to adapt to possible deviations in such environmental conditions,
the plant was evolved to rapidly respond to those changes. Those responses include
Absicic acid stress hormone induction as well as readjustment of the plant transcriptome
to up regulate plant components that are able to promote tolerance of the plant to abiotic
stress. However, it was found that both low and high temperature may not only modulate
abundance of certain transcripts but also promote alterations in their alternative splicing
patterns.[22, 77-79] Recently, alterations in pre-mRNA alternative splicing pattern was
observed in Arabidopsis seedlings under salt stress.[80]
Heat shock transcription factors are key players of plant‘s response to an elevated
7

temperatures through binding to heat shock elements of heat shock proteins genes.[81]
HsfA2 of Arabidopsis is of the most important transcription factors involve in plant’s
thermo tolerance. HsfA2 showed two important post-transcriptional modification through
AS. First, at 37ºC, a 31-bp mini exon in the single intron of HsfA2 is spliced into the
transcript, generation HsfA2 II transcript. This exon retains a PTC that leads to direction
of the transcript to NMD, thus regulation the level of HsfA2 active protein.[82] Second, at
42ºC, another 5’ cryptic splice site is activated and resulting in another transcript, HsfA2
III. This transcript codes for a truncated protein, S-HsfA2. This short protein retains a
helix-turn-helix DNA binding motif and it was found to bind to HsfA2 promoter heat
shock elements, resulting in enhancement of its own transcription. At 45ºC, only HsfA2
III was detected rather than HsfA2 II transcript.[83] Such positive feedback loop through
AS post-transcriptional modification is a great example of AS involvement in gene
expression regulation during response to stress.

1.5.2 SR proteins Alternative splicing in plant stress responses
Pre-m-RNA of Arabidopsis SR proteins has tend to show extensive AS under the
influence of various environmental stresses and hormones. [22, 80, 84, 85] High salinity
stress was found to introduce PTCs into the mRNA of several SR proteins through usage
of alternative 5’, 3’ splice sites or intron retention events. 15 of the 18 Arabidopsis SR
proteins tested showed altered pattern of alternative splicing when grown in high salinity
environment. [80]
Further, a lot of SR proteins exhibit different AS under extreme temperatures.
AtSR30 full intact ORF spanning transcript was enhanced at high temperatures and high
light density. However, the unproductive PTC-containing transcript was suppressed under
high temperatures.[22] Likewise, under dehydration stress, it was observed that SR45a,
atypical SR-like protein, full functional transcript abundance increased relative to other
splice variants.[86] All those findings were consistent with the suggested role of posttranscriptional AS as an efficient regulator of functional transcripts and proteins
abundances under stress conditions.
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1.6 Signals coupling to alternative splicing regulation
Rapid reprogramming of the plant’s transcriptome and proteome complexity upon
stress signal is a necessity to provide a real time response to this stress. Pre-mRNA
splicing was found to be regulated by external signals in various studies. [30, 87-89] The
mechanisms through which pre-m-RNA splicing is altered by signals in plants are not
fully identified.
Posttranslational modifications of splicing factors and splicesomal components,
specifically through phosphorylation, was found to regulate splicing in animals.
Interestingly, many protein kinases that phosphorylate splicing factors have already been
discovered in plants. [90]Moreover, many SR proteins and other splicing regulators were
identified as phosphoproteins through phosphoproteomic analysis. [91] Hence, it may be
possible that second messengers, like calcium or reactive oxygen species, can modulate
the phosphorylation status of splicing modulators through controlling their corresponding
kinases and phosphatases’ activity. [91] One example of complex regulatory loop that
spans AS, NMD as well as phosphorylation is AFC2 gene in Arabidopsis, which codes for
LAMMER kinase. This protein is able to phosphorylate SR proteins as well as other
splicing factors. In previous research, it was revealed that exon skipping AS events in
AFC2 resulted in alternative transcripts that are coupled to NMD, thus lead to alteration of
AFC2 functional transcripts abundance. Consequently, any change in LAMMER kinase’s
abundance can modulate the phosphorylation status as well as activity of SR splicing
factors, which in turn modulate alternative splicing.[92] This complex feedback loop of
AFC2 gene exemplify the complex nature of coupling between posttranscriptional and
posttranslational modification in shaping the plant’s transcriptome, especially during
response to stress signals.
As many RBPs including splicing factors was found to be sumoylated in global
proteomic studies, it is possible that sumolylation is involved in splicing factors activity
modulation and AS regulation. [93] Further, changes in cellular environmental conditions
might impact RNA secondary structure and promote splicing pattern alteration. Evidence
for RNA structure changes in response to ion and osmolyte concentration or temperature
have already been provided in previous research. [94-97]
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1.7 Alternative splicing modulating drugs
Alternative splicing has been associated with different neurological and muscular
diseases. [98-100]. Various studies showed that alternative splicing is contributing to the
disease development through changing the topology, solubility and signal peptides of
integral membrane proteins.[101] Further, aberrant splicing events have been identified in
Parkinson’s disease.[102] More specifically, in Spinal Muscle atrophy (SMA), the
survival motor neuron (SMN) protein was revealed to be down regulated due to it exon
skipping event of exon 7 from SMN m-RNA.[103] In cancer related genes, alternative
splicing has been recruited to promote oncogenesis, tumor suppression[104] and
metastasis.[105] Changes in alternative splicing patterns have been found in various types
of cancer. [104-107]
Therapies for human diseases as well as cancer therapies through splicing
modulation have been developed.[108-110] Therapeutic approaches in splicing associated
diseases include mainly restoring splicing through Antisense Oligonucleotides (ASO) and
targeting splicing pathways through small molecules.
To restore splicing, as ASO is used to target and specifically bind to 12-50
complementary nucleotides to sterically block splicesomal components interaction with
splicing enhancers, and thus lead to exon skipping, or splicing silencers, and thus result in
exon inclusion. The efficiency of the approach has been proved through using mouse
model for SMA disease. Using an intracerebroventricular (ICV) injection of one ASO
(ASO-10-27) lead to dose-dependent enhancement of exon 7 inclusion, SMN protein
synthesis, improved muscle physiology, motor function and survival rates.[111]
Interestingly, systemic delivery of (ASO-10-27) lead to increase of SMN protein level in
both peripheral and central nervous system as well as increase survival from 10 days to
500 days[112]. Collectively, these good results in mouse models encouraged FDA to grant
an approval on human clinical trials.
Through the small molecules approach, different splicesomal components or
splicing factors can be targeted and lead to radical alterations in alternative splicing
patterns. Many antitumor drugs have been found to possess splicing inhibition properties.
Those drugs include herboxidiene, spliceostatin A, pladienolide and isoginkgetin.[11310

116].

All those drug showed antitumor potency over human cancer cell lines and
xerograft mouse models.[115, 117-119] Herboxidiene and pladienolide B are structurally
similar and both act through binding to SF3b components of the U2 snRNP thus inhibiting
U2 snRNP function. Spliceostatin A also target a protein that is a component of U2
snRNP, but rather than promoting general splicing inhibition, it initiates alterations in
splicing of cell cycle genes. [120]
Cdc-2 like kinases (Clk kinases) are involved in phosphorylation of SR proteins, a
process found to be critical for SR proteins activity and nuclear localization. [121,
122]Targeting splicing through inhibition of such kinases can alter the activity of SR
proteins splicing regulators. In previous studies, screening for molecules that alter the
splicing of BCL-X, HIPK3, and RON transcripts hepatocarcinoma cell line have found
amiloride as potent splicing modulator of those transcripts.[123] Cells treated with
amiloride showed hypophosphorylated SR proteins and decreased level of SFSP3
(SRp20).[123] Consequently, small molecules altering the activity of certain splicing
factors can be used to modulate the alternative splicing of cancer- related genes and thus
exhibit therapeutic potentials.

1.8 Selective alteration of alternative splicing through targeting serine
arginine rich splicing factors by Indole derivatives.
Compounds of the Indole derivatives have proven to be potent splicing inhibitors.
Derivatives of Indole chemical nucleus showed the ability to specifically inhibit exonic
splicing enhancer ESE dependent splicing. This action is mediated by direct and selective
interaction with the members of serine-arginine rich proteins family. [124]
It was early revealed that drugs that hinder kinase activity of topoisomerase I, and
thus disrupt the phosphorylation status of SR proteins, showed a splicing inhibition
potential and altered the splicing pattern of many genes.[125, 126] SR proteins
phosphorylation posttranscriptional modification was shown to be essential for ESEdependent splicing. [127] Indole derivatives was found to prevent phosphorylation of RS
domain of SR proteins by topo I kinase and to lesser extent by Clk-sty kinases. However
some Indole derivatives were able to inhibit both ESE events associated with SC35 or
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SF2/ASF SR proteins, some other derivatives had specificity to one SR proteins.[124]
HIV-1 uses various 5’ or 3’ alternative splice sites to generate more than 40
different m-RNA and proteins for its replication. This process is mediated by interaction
of specific HIV m-RNA with SR proteins [128]. Remarkably, compounds of Indole
derivatives showed potent inhibition of HIV-RNA production in HIV chronically infected
cells. Selective and direct interaction of Indole derivatives with SR proteins family
members may explain the splicing inhibition and alteration of HIV-1 m-RNA appeared
under the influence of Indole derivatives. [124]
Further confirmation of the therapeutic potentials of Indole derived drugs (IDCs)
have been demonstrated through targeting ESE dependent splicing involved in cancer
metastasis.[129] Ron (Recepteur d’origine nantais) proto-oncogene produces four
different m-RNA transcripts. One specific transcript Δ Ron, generated through exon 11
skipping event, has been associated with enhanced cell motility [130-132]. This splicing
event has further linked to Epithelial- Mesenchymal transition process (EMT) and
metastasis [133]. On molecular level, splicing of exon 11 is mediated through two
elements, an exon silencer and exon enhancer, both present in constitutive neighboring
exon 12.[134] Direct binding of SF2/ASF SR splicing factor, proto-oncogene up-regulated
in many human tumors[135], to the enhancer sequence on exon 12 result eventually in
formation of Δ Ron transcript with its consequences on cell motility and EMT. [134]
HeLa cells characterized by their preferential skipping of Ron exon 11 and
expression of Δ Ron transcript has been treated with 4 different IDDs Indole derivative,
which showed previously potent inhibition of SF2/ASF ESE-dependent splicing. Three
different IDCs, namely IDC48, IDC78 and IDC92 (nomenclature according to the original
study) were found to specifically inhibit skipping of exon 11 and reduce the levels of Δ
Ron transcript. More importantly, dose effective curve showed that drug IDC92 was
potent in Ron exon 11 inclusion even at 0.5 µm while Δ Ron became the less abundant
transcript at 4 µm, yet such concentration yield modest effect on Caspase9 transcripts
alternative splicing[129]. Collectively, all those findings support the therapeutic potency
and specificity of targeting SR proteins mediated ESE-dependent alternative splicing by
Indole derivatives.
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1.9 Study objectives and design
In this study, we are trying to modulate alternative splicing in plants through
targeting serine-arginine rich proteins splicing factors by three different Indole derivatives,
6-Methylindole, 2, 5-Dimethylindole, 5-Bromoindole-2-Carboxylic Acid. Different
derivatives of Indole nucleus have showed potency in inhibition of ESE dependent
splicing in both in-vitro splicing systems and cell lines. To our knowledge, this is the first
study to target ESE dependent splicing in plants.

This study aims mainly to reveal the scope of splicing alterations promoted by the
three Indole derivatives under study. Splicing alterations shall be described in terms of
global enhancement or decrease of AS under the effect of this derivatives. This study
further investigate the functional categorization of genes experienced isoform shift
between each treatment and control. Moreover, due to nature of coupling between gene
expression and AS, the study aims too to elaborate the differential gene expression
promoted by alteration in AS under Indole treatment. Finally, the study tries to give more
insights into the potential molecular function changes or outcomes of certain differentially
spliced transcripts to investigate the complex feedback and cross-regulatory roles between
gene expression, post-transcriptional and post-translational modifications.

To achieve those objectives, paired-end RNA-seq of 32 samples (4 replicates*2
time points* 4 conditions [1 control + 3 treatments) was used to give a snapshot of the
transcriptome in different control, treatments and time points. Data generated was further
analyzed for alternative splicing changes using JuncBASE, differential expression analysis
using Tuxedo protocol, and functional insights into the differentially spliced transcripts
using Integrative Genomic Viewer (IGV) visualization tool.
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Fig 1.1 Mechanism of Splicing and splicesomal assembly on splice site.

[136]
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Fig 1.2 Cis acting factors and types of alternative splice events..
[54]
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Fig 1.3 Alternative splicing regulation through trans-acting splicing factors.

[31]
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CHAPTER 2: MATERIALS AND METHODS
2.1. Samples preparations and treatments
Six days old Arabidopsis Thaliana Col-0 seedlings have been transferred to plates
that contain 6-Methylindole (MW: 131.17), 2, 5-Dimethylindole (MW: 145.20) or 5Bromoindole-2-Carboxylic Acid (MW: 240.05) at the same concentration of 10µm.
Chemicals were ordered from Sigma-Aldrich, prepared in stock solutions of DMSO in
100mM concentration and stored at -20ºC. Each drug treatment was extended to both 24
hours and 72 hours before RNA extraction. Control samples that received no treatment
were prepared and harvested for RNA extraction also at both 24 and 72 hrs time points.

2.2. RNA extraction, library preparation and sequencing
Whole seedlings have been used for subsequent RNA extraction and sequencing.
For RNA extraction step, total RNA was extracted first using Triazol method. Strandspecific mRNA-seq library was prepared. Paired end sequencing was performed on
Ilumina Hiseq2000 sequencing platform (Illumina Inc., California, USA).

2.3. RNA-seq reads quality control and quality assessment
Sequencing output included 64 fastq files for 32 samples sequenced in this study,
so that each sample generated one file of reads for each end of any fragment sequenced.
Fastqc(v 0.11.2)[137](available online at
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) has been used to generate
quality reports of all fastq files.
Fastqc reports showed that about 12 to 14 million reads per sample have been
generated during sequencing, with a uniform read length 101. In the reports, per base
sequence quality plots showed no base quality dropped below Phred quality score 33.
Further, there were no overrepresented sequences, adapter content, nor reads flagged as
poor sequences. Per Base N content was absent across all bases. Sequence quality scores
plots showed average quality read around 37 with almost no read with overall quality
below 33. However, a very few (around 9 bases) fluctuation in per base sequence content
was found. Overall, as those results were consistent among the 32 study samples, the
quality of the sequencing seemed promising and no trimming was needed to enhance the
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quality of the data. So, Fastq files were proceeded to the reads mapping and alignment
untrimmed.

2.4 RNA-seq reads alignment and junction prediction
Tophat software[138] has been used to align the generated reads of all the
samples against the latest release of Arabidopsis genome sequence and annotation of gene
models of TAIR10 (TAIR10.30 version), which was downloaded from ensemble plants
File transfer portal at (http://plants.ensembl.org/info/website/ftp/index.html).
As a splice-aware aligner, Tophat first reads known junctions from the annotation
file. From this annotation data, the software builds a transcriptome file that contains
annotated exons and junctions coordinates. After that, Tophat uses Bowtie [139] aligner to
map the RNA-seq reads to this transcriptome.
Interestingly, tophat has the ability to discover novel junctions, those junctions
that their coordinates haven’t been supported by annotation data currently available in
TAIR10 (version TAIR1030). Default parameters have been used in tophat run.
Two important files have been produced from tophat run on each sample of the 32
samples in this study. First, a .bam file that contain the mapping information of the
accepted reads hits. Second, a junction.bed file that contains the information of splice
junctions found/predicted in each sample. In our basic tophat run, novel splice site
discovery feature was enabled, so the output contained information of known as well as
novel junctions. The output of this run, as being the most possible inclusive, has only been
used in all downstream analysis.
Another side tophat run, where novel junction discovery feature is disable, has
been conducted. The purpose of this side run was to gain quantitative information about
difference between known and novel splice junctions per sample. As this run will generate
only known junctions data, comparison with the first basic tophat run, that generate
information about both known and novel combined, has helped to infer statistics about
both types of junctions in each sample. However, this later side run outputs haven’t been
used in any of the downstream analysis.
Tophat version used was v.2.1.0. (https://ccb.jhu.edu/software/tophat/index.html).
This version uses bowtie 2.2.6.0 as an aligner. Both programs were installed and used on
Linux operating system on metagenomics-bio server (IP access 10.7.28.10) of the Biology
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department, School of science and engineering, American University in Cairo. The
terminal was accessed often through secure shell app of Google chrome internet browser.

2.5 Differential gene expression analysis
Mapped reads haven been then used to assemble and quantify all transcripts in
each of our samples, separately, through cufflinks software[140, 141] (v2.2.1), available to
download at (http://cole-trapnell-lab.github.io/cufflinks/install/). Afterwards, annotation of
all possible transcripts from each sample have been merged to generate one annotation file
for all gene models possible in our samples pool. This has been achieved using cuffmerge
program. Further, gene, isoform quantification and differential analysis between control
and treatment in each time point has been performed through cuffdiff program. This
differential expression analysis has been guided by the merged gene models annotation
generated through cuffmerge in the previous step. Finally, visualization of the cuffdiff
analysis output mainly utilized cummrbund bioconducter package
(http://bioconductor.org) that runs on R statistical and computing programming
environment. (https://www.r-project.org) (v3.2.3).

2.6 Alternative splice events annotation from confident splice junctions
JuncBASE[142] (Junction Based Analysis of Splicing Events) protocol has been
followed to accomplish identification and classification of splicing events in each sample.
The protocol utilizes information from splice junction reads alignment of RNA-seq reads
as well as annotated exon coordinates to analyze alternative splicing events. Furthermore,
JuncBASE makes use of read counts assigned to exclusion and inclusion isoforms to
develop “Percent-spliced in” value for each splicing event. JuncBASE software (v0.6)
used in this study is available for download at
(http://compbio.berkeley.edu/proj/juncbase/Home.html)
This protocol can further uses those values to identify splicing events that are
differentially expressed across samples, which indicates a differential alternative splicing.
JuncBASE protocol was initially developed in order to characterize both novel and
annotated splicing events during Drosophila development as well as identify those events
which altered upon knock down of splicing factors.

19

As this study aims mainly to study the consequences of targeting serine-arginine
rich proteins splicing factors on alternative splicing, JuncBASE protocol was a very good
candidate to perform such analysis.
The workflow of JuncBASE starts with building a database for both reference
annotation exons and introns from reference gene models annotation file. The same gene
model reference annotation file used for mapping reads with Tophat has been used for this
step. Afterwards, in order to remove putative false positive splice junctions, a plot of
entropy scores of each sample splice junctions has been generated using plot entropy
feature of JuncBASE. An entropy score is a function of both the total reads assigned to a
certain splice junction, the number of possible different offsets to which those reads map
as well as the number of reads that mapped to every offset.[143] So, splice junctions
where many reads mapped to each of the possible offsets positions across the junction will
receive a higher entropy score than other junctions, where many reads mapped to only one
or two offsets positions.
pi = reads at offset i / total reads to junction window
Entropy = - sumi (pi * log(pi) / log2) [143]
In our study, and based on samples’ splice junctions entropy plots generated, an
entropy score of 2 has been used to filter putative false positive novel junctions. This
value was chosen as it overlaps with normal distribution curve of entropy scores of known
reference annotated junctions. Further, a minimum overhang of 10 alignment of reads on
either side of intron-exon boundary was required to assign this reads to this intron-exon
junction. Those two criteria were used to generate a set of confident splice junctions for
each sample to be used for downstream alternative splicing events identification and
quantification.
To identify and quantify alternative splice events, reference annotation of introns
and exons coordinates, created in first step, has been used to annotate introns, exons,
confirm first and last exons as well as assign gene names and decide whether each splicing
event is novel or previously annotated. Finally, tables of raw and length normalized counts
of both inclusion and exclusion isoforms of every splicing events have been developed to
be used later for differential splicing analysis.
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To generate counts of total and different events types in each sample, tables of length
normalized reads counts for have been opened in Excel sheets (Microsoft office 2013,
Microsoft Inc.). Then, plots of events counts have been generated after reading the tables
in R programming environment through using ggplot2 CRAN package (https://cran.rproject.org/web/packages/ggplot2/index.html).

2.7 Differential alternative splicing analysis
Tables of length normalized exclusion and inclusion counts have been utilized to
calculate percent spliced in values for each event in each samples. Percent spliced in can
be calculated as follows:

Percent spliced in =

To perform differential alternative splicing analysis, paired t statistical test, have
utilized the percent spliced-in values of every splicing event to calculate the p-value of the
difference between each treatment and its corresponding control. In the context of our
study, 6 paired t-test have been conducted between 4 replicates populations of control and
three treatments at two time points. In each comparison, a table of the paired t-test results
containing p-value of the difference in percent spliced in, the type of event, whether the
event novel or annotated, gene name, chr number as well as genomic coordinates of
inclusion and exclusion junctions and isoforms.
Further, the output tables of every paired t-test conducted has been filtered
according to a cut-off p-value. Those events who showed a p-value lower than 0.01 have
been chosen as statistically significant events.
Finally, and in order to determine the biological relevance of statistically
significant events, lists of genes showed statistically significant differential alternative
splicing have been created and submitted to DAVID (https://david.ncifcrf.gov/) for
functional annotations as TAIR IDs (The Arabidopsis Information Resource ID). Results
of functional ontologies and enrichment of each treatment group of genes have further
plotted using ggplot2 in R programming and statistical computing environment.
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2.8 Visualization of differentially expressed alternative splice events
Visualization of the mapped reads to the genome in each sample and compare
differential coverage to certain intronic or exonic sequences among samples can help to
infer the functional consequences of such splice events. To achieve this step, integrative
genomic viewer (IGV) [144] have been utilized to visualize differentially expressed
alternative splice events. IGV starts with reads aligned in .sam format files. So, samtools
have been used to convert .bam files for our 32 samples into .sam files. After that, IGV
tools, feature of IGV, have been used to generate two types of files, sorted and indexed
.sam files of each sample. All files have been loaded on visualization session of IGV to
generate sashimi and coverage plots for differentially expressed alternative splice events.

Fig2.1 Density distribution bar plot of known and annotated splice
junctions in replicate 1 of control sample at 24 hours’ time point.
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Samples preparations and treatments
(1 control+ 3 treatments) * 2 time points
(24 hrs and 72 hrs) =8 samples
4 replicates* 8 samples= 32 all study samples

RNA extraction library preparation and
sequencing
*total RNA extraction
*m-RNA strand specific library
*Paired end sequencing on Ilumina Hiseq 2000

RNA-seq reads quality control and quality
assessment
FastQC

RNA-seq reads alignment and junction
prediction
Tophat

Fig2.2 Flow chart of the study design
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CHAPTER 3: RESULTS AND DISCUSSION
3.1 Global alterations of alternative splicing
From the RNA-seq data, 22478, 19166, 23577, 20897 alternative splice event
have been annotated and discovered by JuncBASE ( with parameters specified at
Materials and Methods) from control, 6-Methylindole, 2, 5-Dimethylindole, 5Bromoindole-2-Carboxylic Acid treated samples at 24 hrs time point, respectively. At 72
hrs time point, 15340,18535,19319,26588 alternative splicing events have been described
(See Fig 3.1). Majority of the events described at 24 hrs time point 4 samples are found to
be novel and not previously annotated at Arabidopsis gene model annotation used. In
contrast, majority of events described at 72 hrs time point were actually annotated. (See
Fig3.2 and Fig3.3). Moreover, counting of each splice event type in each sample has been
performed and plotted (See Fig 3.4). Eight types of alternative splicing events have been
characterized in this analysis. Those events include; alternative donor or alternative 5’
splice site, alternative acceptor or alternative 3’ splice site, cassette exon, alternative first
exon, alternative last exon and intron retention. In Arabidopsis, intron retention and
alternative acceptor have been found to be the most prevalent splicing events, which is
apparently different from humans, where cassette exon (also known as exon skipping) is
the most prevalent splicing event. [22]
Our splicing events analysis has revealed global alterations in alternative splicing
after treatment with Indole derivatives. In 4 out of 6 treated samples, alternative splicing
analysis has showed enhancement of AS under the effect of Indole derivatives relative to
control treatments. More interestingly, all three Indole derivative treated samples at 72 hrs
time point showed enhancement of the alternative splicing. Pattern of splicing
enhancement might seem to increase with the Indole derivative chemical structure
complexity, as the degree of AS enhancement increased gradually under the effect of 6Methylindole, 2, 5-Dimethylindole, 5-Bromoindole-2-Carboxylic Acid, respectively.
However, 2, 5-Dimethylindole treated samples showed AS enhancement at 24 hrs timepoint. Yet, both 6-Methylindole and 5-Bromoindole-2-Carboxylic Acid treated samples
showed decrease in AS relative to the control sample at 24 hrs time point.
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This may suggest that different Indole derivatives exhibit different actions
towards splicing alteration. The fact that the majority of enhanced AS events at 72 hrs
time point are belonging to previously annotated splice junctions or splice events supports
the validity of the AS enhancement and discredit the probability that the enhanced AS
observed may result from false positively discovered splice junction or splice event.
Overall, those observations of global alterations of AS, mainly towards
enhancement, is consistent with the hypothesized action of the Indole derivatives
compounds (IDDs), where the main mechanism of action is an inhibition of ESE
dependent alternative splicing through targeting SR proteins. Such splicing inhibition shall
promote failure of proper splicing or removal of nearby intronic sequences and as a
consequence expand the degree of alternative splicing event. That’s specifically valid and
expected in an organism where intron retention represents the extreme majority of
alternative splicing events. However, it remain unclear why the AS showed decrease in 6Methylindole and 5-Bromoindole-2-Carboxylic Acid treated samples at 24 hrs time point.
More interesting and consistent with the later hypothesis, analyzing alteration in
each type of splicing event separately revealed that always intron retention is the most
altered splicing event. Intron retention, 3’ alternative acceptor and 5’ alternative donor
splicing events alteration pattern is following the same overall splicing alteration pattern
with no exceptions. Intron retention seems to be the most enhanced splicing event
enriched specifically at 72 hrs time point. Samples treated with 5-Bromoindole-2Carboxylic Acid showed almost more than double and half the number of splicing events
appeared in the control samples. Moreover, alterations in exon skipping events, alternative
first and last exon, coordinate exons as well as mutually exclusive exons showed slighter
splicing alterations though those low representation of those splicing events in
Arabidopsis transcriptome may discourage us from drawing conclusions on splicing
pattern alteration they showed.
Collectively, observation of global and event specific splicing pattern alteration
under the influence of Indole derivatives used in this study strongly recommend that after
certain onset of time, 72 hrs, splicing inhibition promoted by those derivatives lead to
significant enhancement of AS, mostly and specifically intron retention splicing events.
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3.2 Differentially spliced genes associated with Indole derivatives treatment
Enhancement of AS under Indole treatment lead to expression of alternative
events that were not expressed in the control. Though, it is further interesting to
investigate the isoform shift associated with each drug treatment and determine the
functional scope of genes experienced such changes. Isoform shift mainly is a phenomena
when a gene has two or more isoforms, yet only one is the most frequent relative to the
others. In certain conditions, this distribution of isoforms is altered, so that the dominant
isoform is shifted to be less frequent relative to one or two of the previously less frequent
ones. Isoform shift may be recruited to produce proteins with altered or modified function,
modify gene expression through NMD or whatever purpose to accommodate
physiological changes associated with development, growth as well as response to
environmental stresses.
JuncBASE produced percent spliced in values (for full description check
Materials and Methods) and it was used to infer isoform shift but on splice event level.
Splice events would be considered to contribute to isoform shift when a statistical
significant (p-value > 0.01) change is observed in percent spliced in values between
control and treated samples. Only events that pass this cut-off p-value limit have been
labeled as significant and utilized in downstream functional analysis. Plots of number of
splice events who passed this cut-off and considered statistically significant differentially
expressed alternative splice events have been generated. Further, plots of the number of
genes experienced isoform shift under Indole treatment conditions at the two examined
time points was plotted to infer how wide the scope of isoform shift promoted by
derivatives under study. Moreover, functional categorization of the genes underwent
isoform shift was determined and plotted to determine the scope of functions affected.
Our results (see Fig3.5) show that 293, 303 and 399 events in 6-Methylindole, 2,
5-Dimethylindole and 5-Bromoindole-2-Carboxylic Acid treated samples, respectively,
showed a statistically significant differential splicing at 24 hrs time point. However,
187,146 and 366 statistically significant events were found, also respectively, at 72 hrs
time point.

26

Moreover, plots of genes exhibited differential splicing (see Fig 3.6)or isoforms
shift showed that 148, 142 and 199 genes at 24 hrs time point and 144,83 and 214 genes
at 72 hrs time point were significantly altered in 6-Methylindole, 2, 5-Dimethylindole and
5-Bromoindole-2-Carboxylic Acid samples, respectively.
Moreover, number of genes differentially spliced got plotted along with the types
of splicing events to infer which splice event type experienced differential splicing more
frequently under our study treatments. Interestingly, Alternative acceptor, rather than
intron retention, was the most frequently differentially spliced event in most of treatments
(see Fig 3.7). Alternative donor and intron retention have been found to be the second and
third most frequently spliced event, respectively. Indeed, this may suggest splicing
inhibition through Indole derivatives may recruit alternative 3’ and 5’ splice sites more
than intron retention to introduce isoform shift in many genes.
Further, functional categorization of all genes got differentially spliced under our
study treatments showed repeated enrichment of two functional categories across most of
treated samples at the two time points, (See Fig 3.8-3.13). First function category enriched
is RNA splicing genes (represented by terms; m-RNA processing, m-RNA splicing, RNAbinding). Most of those genes are found to be also phospho-proteins. This is consistent
with the previous studies which revealed extensive phosphorylation of RNA splicing and
processing proteins[91], which suggests post-translational level of regulation of RNA
splicing genes through phosphorylation. Yet, as Indole derivatives inhibit phosphorylation
of SR proteins and thus render them inactivated, prevalence of auto-regulation of SR
proteins and cross regulation between them and other phospho-proteins splicing factors
can give an a good explanation of the pattern of functional enrichment present. Inhibition
of phospho- proteins serine arginine rich splicing factors lead to frequent alterations in
their splicing patterns, as they tend to undergo auto-regulation of their alternative splicing.
Further, those alteration of SR proteins activity tend to cause alteration in other
RNA processing and splicing factors due to cross regulation among RNA splicing factors.
Glycine rich proteins, especially (GRP7 and GRP8), tend to be the most frequently
splicing factor showed alteration of alternative splicing. More interestingly, enrichment of
the term (kinases) in some samples may suggest a complex feedback or coupling between
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alternative splicing post-transcriptional modification and phosphorylation posttranslational
modification to regulate plant physiological changes and responses.
Another main functional category was found to be enriched in most of sample is
chloroplast-related genes. This category was represented by the terms; chloroplast,
thylakoid, plastid and photorespiration. Such enrichment may suggest retrograde
regulation between chloroplast and nucleus that may be mediated through alternative
splicing. It is further consistent with the recent idea suggesting the role of AS in plant’s
response to light and promotion of photo-respiration. [145]
Finally, enrichment of transcription, transcriptional regulation or nucleic acid
binding related genes among differentially alternatively spliced genes in some treated
samples may confirm another way of controlling expression level of downstream target
genes through other than NMD which includes AS of transcription factors.

3.3 Differential gene expression analysis
Gene expression differential analysis revealed that 9179,9325 and 12327 genes
have been found to be differentially expressed between control and 6-Methylindole, 2, 5Dimethylindole and 5-Bromoindole-2-Carboxylic Acid treated sample treated samples at
24 hrs time point, respectively. Also, 8870, 9140 and 9439 genes were further
differentially expressed, in the same treated samples order, at 72 hrs time point.
Differentially expressed genes are only those which showed differential expression pvalue <0.01.
Due to that huge number of genes differentially expressed (which ranges from 2535% of around 33 thousand genes in Arabidopsis), list of genes that showed the highest
expression difference were generated by filtering genes (>=450) absolute expression
difference in FPKM unit. Clustered heatmaps of those genes were also plotted for each
pair of comparison in this study. (See Fig 3.13-3.20).
Clusters of genes differentially expressed along different samples ( check Table
3.1 and 3.2) and time points showed potential consistency which may infer similarity in
expression alteration in response to Indole derivatives under study. Most importantly,
different members of photosystem, photo-respiration and photosynthesis have been found
to be differentially expressed in almost all treatments.
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Those members include; RBCS1A, RIBULOSE BISPHOSPHATE
CARBOXYLASE SMALL CHAIN 1A, RBCS2B, RBCB3 all belong to RBSCO family
known for its involvement in carbon fixation using light. Further, Light Harvesting
complex of photosystem II family members; LHC1A, LHC1B, and others were also
frequently differentially expressed. In most treatments, up-regulation of those genes have
been observed, especially at 24 hrs time point treated samples. Yet, down-regulation of
those photosynthesis related families have been observed under some treatments.
Both of our differential expression and splicing findings reveal that
photosynthesis and photorespiration related genes are frequently altered on the level of
alternative splicing and gene expression under the effect of Indole derivatives used in our
study. Those findings strongly indicate regulation of photorespiration by AS. Overall, this
is consistent with the recent findings that Phytochrome A and B both modulate gene
transcription and alternative splicing in response to light and to promote photorespiration
in Arabidopsis. [145]

3.4 Functional consequences of specific alternative splicing events promoted
by different Indole derivative.
To get more insights into the molecular aspects of differential alternative splicing
promoted by Indole derivatives under study, we utilized Integrative genomic viewer to
plot three of the most statistically significant differentially splicing events in order to try to
get more sense of the potential outcome of such splicing alteration.
First, plots of coverage data in both control and 2, 5-Dimethylindole of hydrolaselike protein (AT5G17670) against the annotated gene model (see Fig 3.21) revealed a
differential usage of novel 5’ splice site. First GT splice site has already been annotated in
gene model and second splice site GT is a novel splice site that has been discovered in our
data. Strikingly, this lower differential inclusion of 4 bases through alternative 5’ splice
site under 2, 5-Dimethylindole treatment lead to skipping of UAG( TAG on DNA level)
pre-mature termination codon. Such pre-mature termination codon can have severe
consequence on the abundance or functionality of protein, either through PTC-containing
transcript degradation through NMD or through producing truncated protein. This 5’
alternative splice event has been discovered through JuncBASE and differential 5’
alternative donor was noted as statistically significant (p-value<0.01).
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Another interesting example of alternative splicing alteration in our study is
SR34A differential exon skipping. (See Fig 3.22) SR34A is a splicing factor and one of
serine-arginine rich proteins splicing factor, which is hypothesized to be targeted by
Indole derivatives and is known for auto-regulating itself. Differential exon skipping
under the effect of 2, 5 Dimethyl Indole and 6-Methyl Indole relative to control was
discovered by JuncBASE and noted to be statistically significant alternative splicing event
(p-value<0.01). Although this exon have been annotated in previous studies, no
information about the functional consequences of exon skipping is available. Yet, the fact
that the exon lies in the 5’ untranslated region of the gene model may indicate that
skipping this exon may help the m-RNA generated to bypass regulatory mechanisms that
target this area, like microRNA, in a similar fashion to metazoan. [146]
Finally, differential Intron retention event between control and 2,5Dimethylindole at 72 hrs time point of CPK28 calcium dependent protein kinase was
noted to be statistically significant (p-value<0.01). This novel intron retention has never
been annotated in previous studies and its function remains to be elucidated. Yet, such AS
mediated functional alteration of a protein kinase can further infer a strong coupling
between AS and Phosphorylation, which was suggested by multiple findings in this study.
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Fig3.1 Total AS events distribution. Counting of all splicing events discovered and
supported by splice-junction reads from each control and treatment samples at both 24
hrs and 72 hrs time points.
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Fig3.2 Annotated and Novel AS events distribution. Comparison of annotated and
novel events annotated and discovered in each sample at 24 hrs time point.

32

Fig3.3 Annotated and Novel AS events distribution. Comparison of annotated and
novel events annotated and discovered in each sample at 72 hrs time point.
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Fig3.4 Different AS events distribution. Plots of every splicing event on each sample
at two time points. Splicing events plotted from the left to right in each graph are;
alternative acceptor or 3’ splice site, alternative donor or 5’ splice site, alternative first
exon, alternative last exon, co-ordinate exon, exon skipping, intron retention, mutually
exclusive exons, and total alternative exons.
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Fig3.5 Distribution of statistically significant differentially expressed splicing
events. Plot shows the number of events differentially spliced at 0.01 p-value. Paired ttest statistical test used percent spliced in values of each splicing event between control
and each treatment at the same time point to infer differential splicing.

35

Fig3.6 Distribution of statistically significant differentially spliced genes. Plot
shows the number of genes differentially spliced at 0.01 p-value. Paired t-test statistical
test used percent spliced in values of each splicing event between control and each
treatment at the same time point to infer differential splicing.
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Fig 3.7 Genes distribution according to event splice type affecting it. Plots of genes
differentially spliced by each splice event type in each sample at two time points.
Splicing events plotted from the left to right in each graph are; alternative acceptor or 3’
splice site, alternative donor or 5’ splice site, alternative first exon, alternative last exon,
exon skipping, intron retention and mutually exclusive exons.
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Fig 3.8 Functional categorization of differentially spliced genes between control
and 6-Metlyindole treated samples at 24 hrs time point. Plot contain functional
categorization of differentially expressed genes between Control and 6-Methylindole
treated samples at 24 hrs time point has been generated by David Functional annotation
tool. All categories plotted exceed 1.3 log10 (1/p-value) cut-off value which is
equivalent to 0.05 p-value.
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Fig 3.9 Functional categorization of differentially spliced genes between control
and 6-Metlyindole treated samples at 72 hrs time point. Plot contain functional
categorization of differentially expressed genes between Control and 6-Methylindole
treated samples at 72 hrs time point has been generated by David Functional annotation
tool. All categories plotted exceed 1.3 log10 (1/p-value) cut-off value which is
equivalent to 0.05 p-value.
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Fig 3.10 Functional categorization of differentially spliced genes between control
and 2, 5-Dimethylindolelyindole treated samples at 24 hrs time point. Plot contain
functional categorization of differentially expressed genes between Control and 2,5Dimethylindole treated samples at 24 hrs time point has been generated by David
Functional annotation tool. All categories plotted exceed 1.3 log10(1/p-value) cut-off
value which is equivalent to 0.05 p-value.
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Fig 3.11 Functional categorization of differentially spliced genes between control
and 2, 5-Dimethylindolelyindole treated samples at 72 hrs time point. Plot contain
functional categorization of differentially expressed genes between Control and 2,5Dimethylindole treated samples at 72 hrs time point has been generated by David
Functional annotation tool. All categories plotted exceed 1.3 log10 (1/p-value) cut-off
value which is equivalent to 0.05 p-value.
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Fig 3.12 Functional categorization of differentially spliced genes between control
and 5-Bromoindole-2-Carboxylic Acid treated samples at 24 hrs time point. Plot
contain functional categorization of differentially expressed genes between Control and
5-Bromoindole-2-Carboxylic Acid treated samples at 24 hrs time point has been
generated by David Functional annotation tool. All categories plotted exceed 1.3 log10
(1/p-value) cut-off value which is equivalent to 0.05 p-value.
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Fig 3.13 Functional categorization of differentially spliced genes between control
and 5-Bromoindole-2-Carboxylic Acid treated samples at 72 hrs time point. Plot
contain functional categorization of differentially expressed genes between Control and
5-Bromoindole-2-Carboxylic Acid treated samples at 72 hrs time point has been
generated by David Functional annotation tool. All categories plotted exceed 1.3 log10
(1/p-value) cut-off value which is equivalent to 0.05 p-value.
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Fig 3.14 Volcano plots of expression alterations under (A) 6-Methylindole at 24 hrs
time point (B) 6-Methylindole at 72 hrs time point(C) 2, 5-Dimethylindole at 24 hrs
time point (D) 2, 5-Dimethylindole at 72 hrs time point (E) 5-Bromoindole-2Carboxylic Acid at 24 hrs time point (F)5-Bromoindole-2-Carboxylic Acid at 72 hrs
time point.
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Fig 3.15 Heatmap of top differentially expressed genes between control and 6Methylindole treated samples at 24 hrs time point. Genes plotted are ones which
showed expression difference more than or equal to 450 between two samples.
Clustering of genes through correlation have been done through hclust function in R
statistical programming environment.
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Fig 3.16 Heatmap of top differentially expressed genes between control and 2, 5Dimethylindole treated samples at 24 hrs time point. Genes plotted are ones which
showed expression difference more than or equal to 450 between two samples.
Clustering of genes through correlation have been done through hclust function in R
statistical programming environment.
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Fig 3.17 Heatmap of top differentially expressed genes between control and 5Bromoindole-2-Carboxylic Acid treated samples at 24 hrs time point. Genes plotted
are ones which showed expression difference more than or equal to 450 between two
samples. Clustering of genes through correlation have been done through hclust
function in R statistical programming environment.
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Fig 3.18. Heatmap of top differentially expressed genes between control and 6Methylindole treated samples at 72 hrs time point. Genes plotted are ones which
showed expression difference more than or equal to 450 between two samples.
Clustering of genes through correlation have been done through hclust function in R
statistical programming environment.
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Fig 3.19. Heatmap of top differentially expressed genes between control and 2, 5Dimethylindole treated samples at 72 hrs time point. Genes plotted are ones which
showed expression difference more than or equal to 450 between two samples.
Clustering of genes through correlation have been done through hclust function in R
statistical programming environment.
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Fig 3.20 Heatmap of top differentially expressed genes between control and 5Bromoindole-2-Carboxylic Acid treated samples at 72 hrs time point. Genes plotted
are ones which showed expression difference more than or equal to 450 between two
samples. Clustering of genes through correlation have been done through hclust
function in R statistical programming environment.
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Fig 3.21 Differential usage of alternative 5’ splice site that skips a pre-mature
termination codon between control and 2, 5-Dimethylindole of hydrolase-like
protein (AT5G17670). Comparison between differential inclusion of a pre-mature
termination codon (highlighted in red square) between control sample (top four panels)
2, 5-Dimethylindole treatment (lower four panels). This differential inclusion is
achieved through differential usage of two splice sites. First GT splice site (left purple
circle) has already been annotated in gene model (plotted at bottom of the shot). Second
splice site GT (right purple circle) is a novel splice site that has been discovered in our
data. This 5’ alternative splice event has been discovered through juncBASE and
differential 5’ alternative donor was noted as statistically significant (p-value<0.01).
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Fig 3.22 Differential exon skipping event in control vs. both 6-MethlyIndole and 2,
5-Dimethylindole treated samples at 24 hrs of SR34A serine arginine rich protein
splicing factor. Comparison between differential inclusion of exon 2 (highlighted in
black square) between control sample (top four panels), 6-MethlyIndole (middle four
panels) and 2, 5-Dimethylindole treatment (lower four panels). Less inclusion of exon 2
under the effect of both 6-MethlyIndole and 2, 5-Dimethylindole than control sample is
observed. This exon skipping event has been annotated in genome reference gene
model and differential exon skipping was noted as statistically significant (pvalue<0.01).
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Fig 3.23 Differential Intron retention event between control and 2,5Dimethylindole at 72 hrs time point of CPK28 calcium dependent protein kinase.
Comparison between differential inclusion of intron (highlighted in black square)
between control sample (top four panels) 2, 5-Dimethylindole treatment (lower four
panels). This novel intron retention event has been discovered through juncBASE and
differential intron retention was noted as statistically significant (p-value<0.01).
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Table3.1. Differentially Expressed genes between control and
treatments at 24 hrs time point

6-MethyIndole

LHCB1.3
PSAK
S-ACP-DES6
LHCA3
AT1G62480
ADH1
PSBR
AT1G07590,MT1A
AT1G08115
PSAO
GAPC2
DRT112
LHCB1.2
PSAF
PSAG
RBCS-1A
GASA1
ATEXT4
AT2G01021
GRP3S
GRP3
AT2G15960
AT2G16586
AT2G26500
LHB1B1
DOT1
RPS31
AT2G45180
AHB1
LHB1B2
RCA
CPuORF9,SAMDC1
BAS1
DJ1A
AT3G15450
AT3G41768,AT3G41979

2,5

5-Bromoindole 2-carboxylic

Dimethylindole

acid

AT1G03220
AT1G19020
LHCB1.3
PSAK
AT1G32920
AT1G56220
LHCA3
ACO2
RPL10C
ADH1
PSBR
AT1G07590,MT1A
AT1G08115
GAPC2
PCR1,PCR2
LHCB1.2
PSAG
RBCS-1A
CPuORF28
GASA1
ATEXT4
GSTU19
AT2G01021
GRP3S
LHB1B1
DOT1
ERD15
AT2G45180
AHB1
RBG7
LHB1B2
AT2G38240
GAPC1
DJ1A
RAP2-3
HR4

AT1G03220
AT1G05562
SRC2
GSTU24
ARF2-A
LHCB1.3
LHCA3
ACO2
AT1G62480
RPL10C
ELF5A-3
OPR1
ADH1
PSBR
AT1G07590,MT1A
AT1G08115
PCR1,PCR2
LHCB1.2
PCR8
ALDH7B4
PSAG
AT1G60730
RBCS-1A
CPuORF28
ATKTI1
GASA1
ATEXT4
GSTU19
AT2G01021
GRP3S
GRP3
AT2G16586
CYP19-1
LHB1B1
DOT1
ERD15
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LHCA2
AT3G03270
MT3
PSAH1
TCTP
PSBT
TIP1-2
LHCA4
LHCA1
CURT1A
PETC
LHCB5
STR15
SAG21
AZI1
FSD1
AT4G27450
PSAE1
XTH24
PCKA
FBA2
AT5G01520,LHCB4.1
ASP2
RFS6
GLN2
LHCB3
THI1
PSBO1
MT2B
RBCS-3B
RBCS-1B
AT5G43580
PER71
AT5G65207

BCA1
AT3G03270
MT3
TCTP
TIP1-2
LHCA4
LTP5
LHCA1
CURT1A
AT4G08555
LHCB5
XTH23
STR15
AT4G39675
SAG21
FSD1
AT4G27450
XTH18
PDC1
ASP2
LHCB3
PSBO1
RBCS-3B
RBCS-2B
AT5G65207

AT2G45180
AT2G47720,GSTF8
AGT1
AHB1
RBG7
GSTU7
LHB1B2
GAPC1
DJ1A
AT3G15450
RAP2-3
HR4
DOX1
AT3G03270
HEL
BGLU23
MT2A
TIP1-2
LHCA4
AAE3
LHCA1
CURT1A
AT4G08555
LHCB5
AT4G33560
STR15
AT4G39675
AT4G01860,AT4G01865,AT4G01870
SAG21
AZI1
FSD1
AT4G27450
PDC1
PCKA
AT5G01520,LHCB4.1
AT5G19440
ASP2
RAN1,RAN2,RPT6B
AT5G26280,AT5G26300
ATCP1
AT5G51830
LHCB3
BGAL4
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EXL2
PSBO1
AT5G66985
FER1
MT2B
AT5G16960,P1
RBCS-3B
RBCS-2B
UBC10
AT5G54940
AT5G61820
PER71
AT5G65207
ORF111D,RRN5
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Table3.2. Differentially Expressed genes between control and
treatments at 72 hrs time point

6-MethyIndole

LHCB1.3
PSBR
AT1G07590,MT1A
ELP
SNOR105
LHCB1.2
AT1G54410
RBCS-1A
AT2G16586
TIP1-1
ERD15
AT2G45180
LHCB2.2
LHCB2.1
PSBX
AT2G10940
LHB1B2
COR15B
COR15A
AT3G15450
CCL
BCA1
BGLU23
LHCA4
AT4G30650
AGP15
KIN2
SNOR108
LHCB3
THI1
RBCS-3B
RBCS-2B
RBCS-1B
XTH22

2,5

5-Bromoindole 2-

Dimethylindole

carboxylic acid

PSBP1
CAT3
LHCB1.3
PSAK
FD2
LHCA3
PSBR
AT1G07590,MT1A
PSAO
ELP
LHCB6
DRT112
SNOR105
PSAF
PSAG
RBCS-1A
GLP1
AT2G01021
AT2G16586
PSAE2
LHB1B1
ERD15
AT2G45180
PSBX
AT2G10940
RBG7
PSBW
AT2G33830
LHB1B2
LHCB4.2
AT3G15450
CCL
LHCA2
BCA1

PSB27-1
PSBP1
MT1C
APX1
FD1
GSTU24
LFNR2
RPL34
LHCB1.3
PSAK
PRK
GAPB
PSAH2
FD2
LHCA3
PSBR
AT1G03140,PSAD2
AT1G07590,MT1A
PSAO
ELP
GAPA2
LHCB6
DHAR1
DRT112
EXT3
AT1G21500
SNOR105
LHCB1.2
PSAF
AGP21
PSAG
RBCS-1A
PSBY
GLP1
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MT2A
MT3
PSAH1
PSBT
LHCA4
LHCA1
CURT1A
LHCB5
PSAL
PSBQ1
PSAD1
PSBQ2
FSD1
PSAE1
AT5G01520,LHCB4.1
AT5G02160
SNOR108
LHCB3
THI1
PSBO1
RBCS-3B
PSAN
ORF111D,RRN5

GSTU19
RPS17
AT2G01021
PDF2.3
GRP3S
AT2G16586
PSAE2
AT2G26500
GSTF9
RPL28
LHB1B1
TIP1-1
RPS31
ERD15
AT2G45180
CURT1B
CP12-1
LHCB2.1
PSBX
AT2G10940
AGT1
RBG7
PSBW
LHB1B2
CP29B
RCA
COR15A
GAPC1
LHCB4.2
BAS1
AT3G15450
TIP2-1
GAPA1
RPL12A
LOX2
TKL-1
LHCA2
CYP20-3
CP12-2
BCA1
BGLU23
MT2A
PGK1,SDRB
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PSAH1
PSBT
TIP1-2
LHCA4
PSBO2
CP29A
RPL17
LHCA1
AT3G63160
CURT1A
PETC
ATPD
LHCB5
PSAL
AT4G16980
TUFA
PSBQ1
ACP4
PSAD1
PSBQ2
GPX6
PER42
CP31A
FSD1
PSAE1
AT4G32260
SSR16
SPE2
SHM1
FBA2
AT5G01520,LHCB4.1
AT5G02160
AGP15
BCA2
KIN2
NUDT24
GLN2
SNOR108
LHCB3
THI1
PSBO1
MT2B
GER3

59

VSP1,VSP2
RBCS-3B
RBCS-2B
RBCS-1B
AT5G42530
XTH22
LTP4
PSAN
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CHAPTER 4: CONCLUSION AND FUTURE
PERSPECTIVES
In this study, 3 different Indole derivatives, 6-Methylindole, 2, 5-Dimethylindole,
5-Bromoindole-2-Carboxylic Acid, have been used to target SR proteins in Arabidopsis 6
days old seedlings. Paired end RNA-seq have been used to provide a full snapshot of the
plant’s transcriptome after treatment at two time points 24 hrs and 72 hrs.
Interestingly, observation of global splicing pattern alteration under the influence
of Indole derivatives used in this study indicate that in most treatments, 4 out of 6, and
specifically after certain onset of time, 72 hrs, splicing inhibition promoted by those
derivatives lead to significant enhancement of AS, mostly and specifically intron retention
splicing events. This finding is strongly consistent with the hypothesis that ESE dependent
splicing inhibition promoted by Indole derivative eventually result in splicing failure and
more retained intron, especially in an organism where intron retention is extremely
prevalent.
Identification of both genes differentially spliced and expressed revealed
similarity in the affected systems and coupling of AS to gene expression. Most
importantly, Photorespiration related genes were frequently and repeatedly altered, on AS
or expression level, under different Indole derivatives treatments and time points. More
interestingly RNA binding proteins and splicing factors were differentially spliced, a
finding that is consistent with the prevalence of auto-regulatory nature of those genes.
Furthermore, insights into the molecular function of events showed differential
splicing under treatment suggest various potential functional outcomes. In hydrolase-like
protein (AT5G17670), novel alternative 5’ splice site skipped a pre-mature termination
codon. In SR34a SR splicing factor, exon skipping event at the 5’ untranslated region may
render the spliced transcript resistant to regulatory pathways target this region similar to
what happens in metazoans. In CPK32 protein kinase, novel intron retention event, which
function is unknown, may suggest an AS mediated alteration of kinase activity. This may
further indicate strong coupling between post-transcriptional splicing and post-translation
phosphorylation.
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Future directions of this research line shall include two main research lines. First,
systematic structure activity relationship of Indole derivatives determination shall be
conducted. More Indole derivatives, beyond those used in this study may be experimented
on in-vitro splicing system and on different SR proteins shall give more insights into the
specificity exhibited by different derivatives. Those studies are critically important for the
development of Indole derivatives as splicing modulators in both therapeutic and research
context.
Moreover, more splicing modulators that target different components of
splicesomal machinery, rather than SR proteins, may be used to reveal more into the
consequences of splicing modulation on Arabidopsis (or other plants)’s transcriptome.
Alteration of AS through AOS against specific splicing event may be further used. This
modulation of AS by targeting different splicing players shall continue to clarify more into
the nature of landscape AS regulation mediated of gene expression, post-transcriptional
and post-translational modifications.
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